EssilorLuxottica: 957,954 New Shares to be Issued for the 2025 Dividend Payment
EssilorLuxottica has announced the payment scheme for its 2025 dividend, combining the issuance of new shares and a cash payout for shareholders who did not opt for payment in securities.
The annual shareholders' meeting had offered the option to receive the 2025 dividend in new shares at a price of €175.06. During the exercise period from May 7 to May 28, 2026 (May 26 for shareholders holding shares in registered form by mail, and May 27 electronically), 41,925,217 options were exercised in favor of the payment in shares. This resulted in the issuance of 957,954 new shares, representing 0.21% of the share capital as of April 30, 2026. These securities will be delivered in payment and admitted to trading on Euronext Paris on June 3, 2026. They confer the same rights as the existing shares and are entitled to the current dividend from their date of issue.
Cash Payment for Non-Participating Shareholders
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Shareholders who did not opt for the payment in shares will receive a cash payment totaling €1,669,314,172 on June 3, 2026.
SectorDispositifs médicaux et optique›Optique / lunetterie
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 22 304 millions d'euros
Quarterly revenue: 22 304 millions d'euros
Revenue growth: 6,8 %
Opportunities identified
Le portefeuille des solutions de gestion de la myopie a progressé de +24 % sur les neuf premiers mois
Les activités traditionnelles (Eyecare & Medtech) ont progressé à un rythme supérieur à +6 %, tant au T3 que sur les neuf premiers mois
Segment Direct to Consumer en hausse de +10,6 % au T3, ventes à magasins comparables à +6,8 %
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
